In 2025, Manitty entered the defence ecosystem through its selection into NATO DIANA, the Defence Innovation Accelerator for the North Atlantic. This moment marked a clear inflection point for the company, placing it among a small group of innovators working at the intersection of healthcare, artificial intelligence, and security.
Yet this step into defence was not a sudden pivot. It was the natural continuation of a journey that began in neuroscience research, driven by a simple but demanding question: how can we better understand the human body in real-world conditions rather than controlled environments.
A scientific foundation in neuroscience
Manitty was originally built on expertise in neuroscience, biomedical engineering, and AI. Its early technological foundation was shaped through Phynitty, the company’s research solution developed for preclinical and animal study applications. This stage was essential in building Manitty’s core capabilities involve capturing, synchronizing, and interpreting complex physiological and neurological signals across a wide range of biological data.
Rather than representing the company’s clinical product line, Phynitty played a foundational role in the development of Manitty’s underlying technology. It enabled the team to deepen its understanding of how to generate reliable biological data, structure multimodal signals, and turn them into meaningful insight.
What emerged from this phase was not simply a research tool, but a technical core that would later support broader applications beyond the laboratory.
Bridging research and operational resilience
Building on its scientific foundation, Manitty expanded its reach into healthcare through DeepMo, a remote patient monitoring solution designed to extend clinical visibility beyond the hospital. By translating the high precision capabilities of Phynitty into a medical context, DeepMo enabled continuous monitoring in real life conditions, allowing clinicians to detect early signs of patient deterioration outside traditional care environments.
As this technology evolved, its relevance to high pressure and unpredictable settings became increasingly clear. The challenges of remote healthcare, such as monitoring movement and stress under limited infrastructure, closely mirror the demands of emergency response and defense operations. Manitty recognized that the same core technology used to monitor brain activity in the lab could be adapted to save lives in the most extreme environments on Earth. This strategic evolution led to the development of specialized diagnostic solutions for combat zones, where real time physiological data is a critical factor in ensuring the survival and readiness of service members.
A Strategic milestone: the NATO DIANA partnership
The selection of Manitty into the NATO DIANA program formalizes its evolution from laboratory research to mission critical defense technology. Chosen from more than 2600 global submissions, Manitty is part of a specialized cohort tasked with responding to pressing security challenges in human health and performance. As one of the innovators advancing to the next phase, Manitty is now adapting its DeepMo technology for freely moving smart monitoring in the most demanding operational environments. These systems are specifically engineered to function where
traditional medical infrastructure is unavailable, providing continuous and real time insights into both physiological and cognitive states.
The robustness of this technology was demonstrated during the Ankara Demo Day, where it was tested under rigorous conditions aligned with NATO standards. By connecting with DIANA’s network of mentors and test centers, Manitty ensures its dual use solutions meet the specific needs of Allied forces. Rather than replacing medical expertise, these systems augment it by offering a critical layer of real time information that supports faster and more informed decision making when time and visibility are limited. This partnership not only validates Manitty’s technical prowess but also integrates its solutions into a broader collective defense and resilience framework.
Continuity and scaling for global impact
What defines Manitty is not a change in direction but a continuity of purpose. Phynitty established the scientific foundation in neuroscience, and DeepMo translated that foundation into healthcare. The current extension into defense builds directly on these core capabilities without altering the underlying scientific approach. This is the essence of Manitty’s dual use model: a single technological core designed to deliver measurable human data across diverse contexts.
As Manitty prepares for its next major milestone, including a planned 1.5 million euro fundraising round in March 2026, the focus shifts to scaling these capabilities for broader deployment. The objective remains consistent: transforming human data into actionable intelligence to support better outcomes. Manitty’s trajectory is not a pivot but a natural progression. It reflects a broader shift in innovation where technology is no longer confined to a single domain. At its heart, Manitty’s work remains grounded in one principle: understanding the human condition in order to better protect it.
